Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 20/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21695285 | 0.84 | MAP3K12 (0.66) | MAP3K12 | |
| SCHEMBL21695266 | 0.81 | MAP3K12 (0.70) | MAP3K12 | |
| SCHEMBL20115322 | 0.79 | MAP3K12 (0.73) | MAP3K12 | |
| SCHEMBL16210547 | 0.78 | MAP3K12 (0.73) | MAP3K12 | |
| SCHEMBL19273643 | 0.78 | MAP3K12 (0.67) | MAP3K12 | |
| SCHEMBL20147768 | 0.76 | MAP3K12 (0.71) | MAP3K12 | |
| SCHEMBL22050896 | 0.76 | MAP3K12 (0.74) | MAP3K12 | |
| SCHEMBL22052464 | 0.75 | MAP3K12 (0.68) | MAP3K12 | |
| SCHEMBL22052028 | 0.75 | MAP3K12 (0.73) | MAP3K12 | |
| SCHEMBL16209931 | 0.75 | MAP3K12 (1.00) | MAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180117044-A1 | BIHETEROARYL COMPOUNDS AND USES THEREOF | GENENTECH, INC. (US) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180117044-A1 | BIHETEROARYL COMPOUNDS AND USES THEREOF | BCHE, SNCA, XDH | MAP3K12 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.